New Zealand markets closed

Evelo Biosciences, Inc. (EVLO)

OTC Markets EXMKT - OTC Markets EXMKT Delayed price. Currency in USD
Add to watchlist
0.04000.0000 (0.00%)
At close: 10:09AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-119,638
-114,527
-122,176
-93,666
-85,472
Depreciation & amortisation
2,075
2,060
2,216
2,026
1,764
Stock-based compensation
16,106
15,158
15,846
8,468
8,165
Change in working capital
-8,545
-9,666
2,068
7,765
3,474
Accounts payable
-956
170
159
837
-585
Other working capital
-105,842
-101,857
-98,244
-74,384
-75,012
Other non-cash items
2,879
4,386
2,102
2,350
255
Net cash provided by operating activities
-105,891
-101,235
-96,725
-73,063
-71,980
Cash flows from investing activities
Investments in property, plant and equipment
49
-622
-1,519
-1,321
-3,032
Purchases of investments
-
-
-
-
0
Sales/maturities of investments
-
-
-
0
55,000
Net cash used for investing activities
81
-622
-1,481
-1,315
51,970
Cash flows from financing activities
Debt repayment
-52,659
-47,610
0
0
-15,000
Common stock issued
79,472
84,544
81,751
54,994
0
Net cash used provided by (used for) financing activities
79,790
81,655
97,540
65,465
4,992
Net change in cash
-27,042
-20,656
-666
-8,913
-15,018
Cash at beginning of period
97,251
69,754
70,420
79,333
94,351
Cash at end of period
71,231
49,098
69,754
70,420
79,333
Free cash flow
Operating cash flow
-105,891
-101,235
-96,725
-73,063
-71,980
Capital expenditure
49
-622
-1,519
-1,321
-3,032
Free cash flow
-105,842
-101,857
-98,244
-74,384
-75,012